Factor | Chander_2008_JoofthScofFoanAg (10263)

Subtherapeutic antibiotic use

Turkey | Adult

14

Description

Self-reported use of antibiotics as feed additives

Resistance Outcomes

Resistance Microbe Outcome
Erythromycin
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Antibiotic use 100.00 7
No use 93.00 15
Tilmicosin
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Antibiotic use 100.00 7
No use 93.00 15
Chlortetracycline
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Antibiotic use 100.00 7
No use 80.00 15
Oxytetracycline
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Antibiotic use 100.00 7
No use 80.00 15
Penicillins, Combinations With Other Antibacterials
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Antibiotic use 100.00 7
No use 93.00 15
Ampicillin
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Antibiotic use 71.00 7
No use 33.00 15
Florfenicol
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Antibiotic use 14.00 7
No use 47.00 15
Neomycin
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Antibiotic use 43.00 7
No use 0.00 15
Gentamicin
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Antibiotic use 57.00 7
No use 0.00 15
Tiamulin
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Antibiotic use 100.00 7
No use 93.00 15
Clindamycin
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Antibiotic use 100.00 7
No use 93.00 15
Sulfadimethoxine
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Antibiotic use 100.00 7
No use 0.00 15
Sulfathiazole
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Antibiotic use 0.00 7
No use 7.00 15
Spectinomycin
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Antibiotic use 71.00 7
No use 0.00 15